|
Structure and Function of the Gut Mucosal Immune System |
|
|
1 | (15) |
|
|
|
|
1 | (1) |
|
Intraepithelial Lymphocytes (IEL) |
|
|
1 | (2) |
|
Lamina Propria Lymphocytes (LPL) |
|
|
3 | (1) |
|
Lymphocyte-Filled Villi (LFV) |
|
|
4 | (1) |
|
|
5 | (1) |
|
Isolated Lymphoid Follicies (ILF) |
|
|
5 | (1) |
|
|
6 | (1) |
|
Lymphoid Structures in the Large Intestine |
|
|
7 | (1) |
|
Mesenteric Lymph Nodes, Part of the Gut Immune System |
|
|
7 | (1) |
|
|
8 | (1) |
|
Liver---Also a Part of the Gut Immune System? |
|
|
8 | (1) |
|
Dynamics in the Gut Immune System |
|
|
9 | (1) |
|
|
9 | (1) |
|
|
9 | (6) |
|
Functional Aspects of the Mucosal Immune System |
|
|
15 | (9) |
|
|
Phenotypically and Functionally Unique Lymphocyte Populations in the Gut Associated Lymphoid Tissue |
|
|
15 | (3) |
|
Mechanisms Governing Non-Responsiveness to Food Proteins and Commensal Bacteria |
|
|
18 | (6) |
|
Recent Progress in Inflammatory Bowel Disease Genetics |
|
|
24 | (11) |
|
|
|
24 | (1) |
|
|
24 | (1) |
|
The Human Genome Project and the Challenge of Complex Genetic Disorders |
|
|
25 | (1) |
|
|
26 | (1) |
|
Association Studies in IBD |
|
|
27 | (3) |
|
|
30 | (5) |
|
Microbial and Dietary Factors in the Pathogenesis of Chronic, Immune-Mediated Intestinal Inflammation |
|
|
35 | (20) |
|
|
|
35 | (3) |
|
Evidence of Bacterial Induction and Maintenance of Intestinal Inflammation |
|
|
38 | (4) |
|
Induction of Mucosal Immune Responses by Bacterial and Dietary Antigens and Adjuvants |
|
|
42 | (6) |
|
|
48 | (7) |
|
Experimental Models of Mucosal Inflammation |
|
|
55 | (43) |
|
|
|
|
55 | (1) |
|
General Features of Models of Mucosal Inflammation |
|
|
56 | (12) |
|
Representative Models of Mucosal Inflammation |
|
|
68 | (12) |
|
Tabular Summary of Models of Mucosal Inflammation |
|
|
80 | (1) |
|
|
80 | (18) |
|
Overview of Role of the Immune System in the Pathogenesis of Inflammatory Bowel Disease |
|
|
98 | (10) |
|
|
|
|
98 | (1) |
|
|
98 | (1) |
|
Crohn's Disease, but Not Ulcerative Colitis Bears the Stigmata of a Th1 Mediated Immune Response |
|
|
99 | (1) |
|
The Role of T Cells in Ulcerative Colitis |
|
|
100 | (1) |
|
The Role of Antibody in Ulcerative Colitis |
|
|
100 | (2) |
|
Nonspecific Effector Mechanisms Down-Stream of the Immune System Cause Tissue Injury in Crohn's Disease and Ulcerative Colitis |
|
|
102 | (1) |
|
The Immune System Fails to Negatively Regulate in CD and UC |
|
|
103 | (5) |
|
The Role of the Epithelial Barrier in Inflammatory Bowel Disease |
|
|
108 | (9) |
|
|
|
|
108 | (1) |
|
Bacteria and the Epithelium |
|
|
108 | (1) |
|
|
109 | (1) |
|
The Epithelial Cell as Effector Cell in IBD |
|
|
110 | (2) |
|
Luminal Antigens, Fate and Processing |
|
|
112 | (1) |
|
IEC and Mucosal Barrier Function/Permeability |
|
|
113 | (1) |
|
|
113 | (4) |
|
Involvement of Dendritic Cells in the Pathogenesis of Inflammatory Bowel Disease |
|
|
117 | (16) |
|
|
|
|
|
|
117 | (1) |
|
Current Views on Dendritic Cell Biology |
|
|
117 | (2) |
|
Intestinal Dendritic Cells |
|
|
119 | (3) |
|
Dendritic Cells in Inflammatory Bowel Disease |
|
|
122 | (4) |
|
|
126 | (1) |
|
Intestinal Macrophages in IBD |
|
|
126 | (1) |
|
|
127 | (6) |
|
Alterations of T Lymphocytes in Inflammatory Bowel Diseases |
|
|
133 | (16) |
|
|
|
|
CD4+ T Cell Subsets in the Intestine |
|
|
134 | (2) |
|
Intestinal T Effector Cells |
|
|
136 | (1) |
|
|
136 | (2) |
|
Intestinal T Regulatory Cells |
|
|
138 | (1) |
|
|
138 | (1) |
|
T-Regulatory-1 Cells (Tr1) |
|
|
139 | (1) |
|
|
139 | (1) |
|
|
140 | (1) |
|
What Drives Effector and Regulatory T Cells in IBD? |
|
|
141 | (2) |
|
|
143 | (6) |
|
The B-Cell System in Inflammatory Bowel Disease |
|
|
149 | (19) |
|
|
|
|
|
149 | (1) |
|
|
150 | (1) |
|
B Cell-Mediated Mucosal Homeostasis in the Normal Gut |
|
|
150 | (2) |
|
Humoral Immunity and Immune Exclusion in IBD Lesions |
|
|
152 | (1) |
|
Local Production of Antibodies to the Indigenous Gut Flora in IBD |
|
|
153 | (1) |
|
Local Production of Anti-Epithelial IgG1 Autoantibodies in Ulcerative Colitis |
|
|
154 | (2) |
|
Local Production and Diagnostic Aid of Other (Auto)Antibodies in IBD |
|
|
156 | (1) |
|
Mechanisms for Induction of Local Proinflammatory B-Cell Responses |
|
|
157 | (4) |
|
IBD Apparently Reflects Break of Oral Tolerance against Indigenous Bacteria |
|
|
161 | (7) |
|
Alterations of Mesenchymal and Endothelial Cells in Inflammatory Bowel Diseases |
|
|
168 | (9) |
|
|
|
|
|
|
|
168 | (1) |
|
|
168 | (1) |
|
|
169 | (1) |
|
|
169 | (1) |
|
Fibroblasts and Myofibroblasts |
|
|
169 | (1) |
|
|
170 | (1) |
|
Human Intestinal Microvascular Endothelial Cells |
|
|
171 | (1) |
|
Integration of Intestinal Immune-Nonimmune Cell Interactions by the CD40/CD40 Ligand System |
|
|
172 | (5) |
|
Role of Mast Cells and Eosinophils in Neuroimmune Interactions Regulating Mucosal Inflammation in Inflammatory Bowel Disease |
|
|
177 | (32) |
|
|
|
|
177 | (1) |
|
Intestinal Mast Cells and Eosinophils |
|
|
178 | (4) |
|
Role of Mast Cells and Eosinophils in Intestinal Inflammation |
|
|
182 | (2) |
|
Structure and Function of The Enteric Nervous System |
|
|
184 | (2) |
|
Mechansims of Mast Cell / Eosinophil-Neuroimmune-Crosstalk in the Gut |
|
|
186 | (5) |
|
Neurophysiological Effects of Mast Cell and Eosinophil Activation |
|
|
191 | (3) |
|
Alterations of Neuroimmune-Crosstalk in IBD |
|
|
194 | (3) |
|
|
197 | (12) |
|
Multiparameter Analysis of Immunogenetic Mechanisms in Clinical Diagnosis and Management of Inflammatory Bowel Disease |
|
|
209 | (10) |
|
|
|
|
209 | (1) |
|
NOD2 and Innate Anti-Microbial Processes in IBD Diagnosis |
|
|
209 | (2) |
|
Anti-Microbial Antibodies and Adaptive Immune Components in IBD Diagnosis |
|
|
211 | (2) |
|
Autoantibodies in IBD Diagnosis |
|
|
213 | (1) |
|
Multiparameter Analysis of Immunogenetic Traits in IBD Diagnosis |
|
|
213 | (6) |
|
The Role of Probiotics and Antibiotics in Regulating Mucosal Inflammation |
|
|
219 | (8) |
|
|
|
219 | (1) |
|
Probiotics: Animal Studies and Clinical Trials |
|
|
219 | (1) |
|
|
220 | (1) |
|
Antibiotics: Animal Studies and Clinical Trials |
|
|
221 | (1) |
|
|
221 | (1) |
|
|
222 | (1) |
|
|
222 | (5) |
|
From Immunogenic Mechanisms to Novel Therapeutic Approaches in Inflammatory Bowel Disease |
|
|
227 | (16) |
|
|
|
|
227 | (1) |
|
|
227 | (1) |
|
|
228 | (1) |
|
Physiological ``Hyporeactivity'' of the Intestinal Immune System |
|
|
229 | (1) |
|
Activation of the Mucosal Immune System in IBD |
|
|
229 | (5) |
|
Novel Therapeutic Approaches |
|
|
234 | (4) |
|
|
238 | (5) |
Index |
|
243 | |